The central concept is the "investment performance guarantee factor". This is the ratio of the total cost of providing all investment performance guarantees in policies referable to a statutory fund, divided by the current policy liabilities of that fund (paras 7 and 8). The factor is expressed as a percentage and must not exceed 5 per cent. The cost of each guarantee is defined as "the increase in the fair value of the financial instrument element that is attributable to the presence of the investment performance guarantees" (para 10). This is a contingent valuation: the fair value of the policy is first calculated without the guarantee, then with the guarantee; the difference is the cost. The valuation must follow the relevant accounting standards, which in the Australian context typically means AASB 13 Fair Value Measurement and AASB 9 Financial Instruments (or AASB 139 for earlier periods) together with the requirements of the Life Insurance Act. The concept of "statutory fund" is critical. Life companies in Australia must maintain separate statutory funds for different classes of business under the Life Insurance Act, and this standard applies to any statutory fund whose business consists of the provision of investment-linked benefits and which includes policies with investment performance guarantees (para 3). Investment-linked benefits are those where the policyholder's benefit is directly linked to the value of a specified pool of assets, and an investment performance guarantee is a promise that the policyholder will receive at least a minimum amount regardless of asset performance. Common examples are capital-guaranteed or minimum-return products. The standard also uses the defined terms from Prudential Standard LPS 001 Definitions, which will include "current policy liabilities", "fair value", and "reinsurance". Policy liabilities must be determined gross of reinsurance for the purpose of the factor (para 9). This prevents a life company from using a reinsurance arrangement to artificially reduce the denominator of the ratio. The standard does not define "investment performance guarantee" itself, so that term will take its meaning from the Life Insurance Act and from LPS 001. The concept of "board responsibility" is stated in the objective and key requirements section: the ultimate responsibility lies with the board. This is reinforced by the broader APRA governance framework which expects boards to approve and monitor compliance with prudential limits.

The standard applies to all life companies registered under the Life Insurance Act 1995, including friendly societies (para 2). This covers both domestic life insurers and eligible foreign life insurance companies, but only in respect of business carried on through Australian statutory funds (para 4). The practical population is the set of insurers that write investment-linked policies with capital or performance guarantees. In Australia this includes major life insurers operating in the superannuation and retail investment markets as well as friendly societies that offer investment bonds with guarantees. The standard does not apply to statutory funds that have no investment-linked business or that have investment-linked policies without any investment performance guarantee (para 3(b)). The board of each life company is the ultimate duty-holder, but the standard imposes obligations on the life company as an entity. Within the organisation, the appointed actuary, chief financial officer, and risk management function will typically be responsible for the underlying calculation and monitoring. The standard also affects policyholders of these funds indirectly. If the guarantee cost approaches the 5 per cent cap, the life company may need to adjust the fund's investment strategy, reduce the level of guarantees on new business, or increase fees. Policyholders of funds that hit the cap may face product changes, higher costs, or the risk that the insurer will exercise contractual rights to vary guarantees. The standard also affects reinsurers. Because policy liabilities are measured gross of reinsurance (para 9), ceding guarantee risk to a reinsurer does not reduce the ratio denominator. Reinsurance may still affect the cost of the guarantee (as it reduces the insurer's net risk), but the ratio is calculated before any such offset. This may influence how life companies structure reinsurance for guaranteed products. Life companies with multiple statutory funds must apply the standard separately to each fund (para 3). This means a company cannot use surplus in one fund to support a higher guarantee ratio in another. Each fund is ring-fenced. Foreign insurers writing business through an Australian branch are also caught, but only for their Australian statutory funds, not their offshore business. The standard has been in effect since 1 January 2013 (para 5), so all affected entities should already have systems in place. The 2023 determination merely replaces the earlier instrument without substantive change to the limit or methodology.

The core duty is set out in paragraph 7: the life company must, at all times, ensure the investment performance guarantee factor of a statutory fund does not exceed 5 per cent. This is a continuous obligation, not a point-in-time test at the end of a reporting period. The company must have systems to monitor the factor in real time or at least frequently enough to detect breaches. The duty to calculate the cost correctly under paragraph 10 requires the company to apply fair value methodology in accordance with accounting standards. This involves determining the fair value of the financial instrument element both with and without the guarantee, and attributing the difference to the guarantee. The company must exercise judgment in selecting the valuation model and inputs, but the standard does not prescribe a specific model. The board bears ultimate responsibility for the calculation and for compliance with the Act in relation to investment performance guarantees. This is stated in the objective and key requirements section (the boxed text). The board cannot delegate away this accountability, although it can rely on management and actuaries for the technical work. There is a duty to be able to demonstrate compliance. The key requirements state the company must "be able to demonstrate that at all times the cost of any investment performance guarantees represents less than 5 per cent of the total policy liabilities". This implies a record-keeping and audit trail obligation. The company must maintain evidence of the calculation inputs, the methodology, and the resulting factor for each fund. The standard also confers a right on APRA: APRA may, by notice in writing to a life company, adjust or exclude a specific requirement in the standard in relation to that life company (para 11). This is a discretionary power. There is no corresponding right for the life company to request such an adjustment, though in practice APRA would likely consider representations. The standard also preserves prior discretionary decisions. Paragraph 12 provides that any approval, waiver, or direction granted under a previous version of the standard (including the predecessor standard LPS 5.02) continues to have effect as if exercised under a corresponding power in the current standard. This gives certainty to companies that relied on earlier APRA determinations. The standard does not grant any new rights to policyholders or third parties. It is a regulatory requirement between APRA and the life company. Policyholders cannot sue for breach of the 5 per cent limit; the limit is a prudential safeguard, not a contractual term.

The standard itself does not specify penalties for breach. It is made under paragraph 230A(1)(a) of the Life Insurance Act 1995, which gives APRA the power to make prudential standards. A failure to comply with a prudential standard is a breach of the Act. The Act provides for civil penalties. Under section 42 of the Life Insurance Act (which this standard is made for), the statutory funds of a life company must at all times have assets at least equal to liabilities, including the cost of investment performance guarantees. If the 5 per cent cap is exceeded, the life company may also be in breach of section 42 if the guarantee cost is not properly accounted for as a liability. The primary enforcement tool for APRA is not a monetary penalty but the range of supervisory powers under the Act. APRA can issue directions under section 130, require the life company to submit a plan to rectify the breach, impose additional capital requirements, restrict or prohibit the writing of new business in the affected fund, and in extreme cases apply to the Federal Court for the judicial management of the company. APRA can also take the breach into account in determining the company's risk rating and supervisory intensity. The board's responsibility is explicitly noted in the standard. If a breach occurs, APRA may regard the board as having failed in its duty. This could lead to APRA using its power to remove or disqualify directors under the Banking Act (applied through the Life Insurance Act provisions) or to take enforcement action against individual directors. The standard requires the life company to be able to demonstrate compliance at all times. If a breach is discovered, APRA will likely examine whether the company had adequate systems and processes. A failure to maintain proper systems could itself be a separate breach of the prudential framework. The fact that policy liabilities are determined gross of reinsurance (para 9) means a company cannot claim that the ratio was lower because of a reinsurance arrangement. APRA may also use its power under paragraph 11 to adjust or exclude a requirement, which could be a tool for remediation. For example, APRA might grant a temporary waiver of the 5 per cent limit subject to conditions. There is no automatic penalty for a first breach; APRA has discretion to respond proportionately. However, the standard has been in force since 2013 and the current instrument is a replacement, so APRA clearly regards adherence as a baseline expectation rather than a novel imposition. Practically, the most severe consequence is not a fine but the restriction of business freedom. A company that exceeds the cap may be forced to stop offering guaranteed products in that fund, which can have significant commercial implications.

The standard is made under paragraph 230A(1)(a) of the Life Insurance Act 1995. Its primary interaction is with section 42 of that Act, which requires a life company's statutory fund to maintain assets at least equal to liabilities. The cost of investment performance guarantees, as calculated under this standard, forms part of those liabilities. If the cost is understated, the section 42 requirement is breached. The standard effectively supplements section 42 by imposing a more specific limit (5 per cent of policy liabilities) and by mandating a particular valuation method. The standard does not override section 42; the section 42 test continues to apply independently. Even if the guarantee factor is under 5 per cent, the fund must still satisfy the general solvency test. Conversely, a fund could satisfy section 42 but breach the 5 per cent cap if its guarantee costs are concentrated. The standard also interacts with Prudential Standard LPS 001 Definitions, which governs the meaning of bolded terms in the standard. When a term appears in bold on first use in LPS 370, it takes the meaning from LPS 001. Relevant terms likely include "current policy liabilities", "fair value", "statutory fund", "investment-linked policy", and "reinsurance". Practitioners need to read LPS 370 together with LPS 001. The standard references "relevant accounting standards" for the fair value calculation. In Australia, those are AASB 13 Fair Value Measurement and the relevant AASBs for financial instruments (AASB 9, or formerly AASB 139). The life company's accounting policies for determining fair value must be consistent with these standards. The APRA Prudential Practice Guide LPG 370 (if one exists) may provide additional interpretative guidance, though it is not binding. The standard specifically preserves prior determinations made under earlier versions. Paragraph 12 states that an approval, waiver, or direction under a previous version of LPS 370 or under LPS 5.02 continues in effect as if exercised under a corresponding power in the current standard. This is important for transitional compatibility. The standard also sits within the broader APRA prudential framework for life insurance: Life Prudential Standards (LPS) cover capital adequacy (LPS 110), governance (LPS 510), and valuation (LPS 340). The guarantee cost calculation under LPS 370 will feed into the capital adequacy calculation under LPS 110, because the guarantee cost is part of policy liabilities and thus part of the base for the prescribed capital amount. For friendly societies that are also life companies, this standard applies equally. Friendly societies have their own regulatory history but are not exempt. Foreign life insurers are covered only for their Australian statutory funds (para 4). The standard does not purport to regulate the overseas business of those insurers. It is also relevant to the Tax Agent Services Act and Corporations Act indirectly, because a misstatement of the guarantee factor in financial reports could lead to exposure under those Acts, but the standard itself creates no direct interaction.

The current instrument is Life Insurance (prudential standard) determination No. 4 of 2023, made by Clare Gibney as a delegate of APRA on 7 March 2023, commencing 29 March 2023. It revokes the previous determination No. 14 of 2012, which contained the earlier version of Prudential Standard LPS 370. The predecessor standard to the 2012 version was Prudential Standard LPS 5.02 Cost of Investment Performance Guarantees. Paragraph 12 of the current standard expressly refers to LPS 5.02 as a previous version. The change from LPS 5.02 to LPS 370 occurred as part of APRA's broader restructuring of the life insurance prudential standards in 2012, which renumbered the standards and aligned them with the new Life Insurance Act provisions. The 2012 to 2023 change appears to have been a routine re-issuance without substantive alteration of the 5 per cent limit or the cost definition. The application date has always been 1 January 2013 (para 5), and that date was carried forward unchanged in the 2023 instrument. The instrument does not include any transitional provisions because it is a re-issue of an existing standard. The footnotes referenced in the text (annotations [1], [2], [3]) are not included in the provided source document, but they are likely the standard footnotes appearing in the official APRA publication. The amendment history is therefore minimal: one replacement of a pre-2012 standard, and one replacement in 2023. There is no evidence of any intermediate amendments or variations. The 2023 determination does not include a table of amendments or a summary of changes. This is consistent with a mechanical re-making rather than a policy change. For practitioners, the practical effect is that any prior approval or direction granted under LPS 5.02 or the 2012 LPS 370 continues to be valid under the new instrument (para 12). This saves affected companies from needing to reapply for existing dispensations. The revocation of the 2012 determination is absolute: the 2012 standard no longer has legal effect from 29 March 2023, but anything done under it (approvals, etc.) is preserved. The current standard is now the only operative version for any period from 29 March 2023 onward. For periods before that date, the 2012 version or LPS 5.02 applied. This matters for any retrospective valuation or dispute about past compliance.

The standard itself is a prudential instrument made by APRA under delegated legislation-making power. As such, it is not directly litigable by a private party except through judicial review of APRA's decisions. There are no cases involving this specific standard mentioned in the source document. Given the standard is a re-issue of a 2013 standard, there may have been litigation over the underlying method or the 5 per cent cap, but the source does not reference any cases. The standard does not confer individual rights, so a policyholder cannot sue a life company for breach of the standard. The standard is used by APRA as a regulatory benchmark, not as a source of private cause of action. Any litigation would most likely involve APRA as a party: either a life company challenging an APRA direction or decision based on the standard, or APRA seeking enforcement against a life company for breach of the standard under the Life Insurance Act. There is no public record of such litigation being litigated to a reported judgment, but that does not mean no enforcement actions have occurred; APRA often resolves matters through administrative action or consent directions rather than court proceedings. The standard's provisions on fair value and accounting standards (para 10) could theoretically be the subject of expert disagreement in a dispute about the correct calculation of the guarantee cost. If a life company and APRA disagree on methodology, the standard does not provide a dispute resolution mechanism beyond APRA's power to adjust or exclude (para 11). That power is unilateral: APRA can impose its view by notice. The life company could then seek judicial review of that notice under the Administrative Decisions (Judicial Review) Act 1977 or the Australian Constitution section 75(v). The grounds would be jurisdictional error, unreasonableness, or procedural fairness. A life company might argue that APRA's decision to adjust a requirement was beyond power or that the adjustment was unreasonable. No such case has been reported. The practical consequence of low litigation history is that the standard operates largely through compliance and supervision rather than through court interpretation. The meaning of key phrases such as "increase in the fair value of the financial instrument element that is attributable to the presence of the investment performance guarantees" has not been judicially considered. This creates some legal risk: the accounting standard bodies and APRA may interpret it one way, but a court could later decide differently. The absence of litigation also means there is no precedent on the standard of proof required to "demonstrate" compliance under the key requirements section.

The most subtle trap is the continuous compliance obligation. Paragraph 7 says "at all times". This is stricter than a period-end test. If a market shock causes the guarantee cost to spike briefly even for a day, the company is technically in breach. The company must have systems to monitor the factor in real time or at least daily. Many life companies may only calculate liabilities monthly or quarterly. That approach is inconsistent with "at all times". A breach may occur before the company is aware. The second trap is the gross-of-reinsurance rule. Paragraph 9 requires policy liabilities to be determined gross of reinsurance. This means the denominator of the ratio is not reduced by any reinsurance ceded. A company that relies heavily on reinsurance to manage guarantee risk may be surprised that the cap bites even though its net economic exposure is much lower. The cap is on the gross cost, not the net cost. This can also distort incentives: a company might do a reinsurance transaction that reduces its economic risk but does not help the ratio. Third, the fair value methodology under paragraph 10 is not simple. It requires the fair value of the financial instrument element both with and without the guarantee. Determining what "without the guarantee" means in a complex product can be difficult. Some companies might use a proxy or a simplified approach that APRA later challenges. The standard does not provide a safe harbour methodology. Fourth, the standard applies separately to each statutory fund (para 3). A company cannot aggregate funds or use surplus from a non-guarantee fund to justify a higher guarantee factor. This is particularly relevant for companies that operate multiple statutory funds and might wish to treat the group as a whole. Fifth, the board's ultimate responsibility (stated in the objective section) is a governance risk. The board must satisfy itself that the calculation is correct and that continuous compliance exists. Many board members are not actuaries. They must rely on management, but they cannot delegate legal accountability. If a breach occurs, the board may be liable for failing to ensure adequate systems. Sixth, APRA's unfettered discretion to adjust or exclude (para 11) is a double-edged sword. It can be used to grant relief, but it can also be used to impose additional conditions. The criteria for exercise are not stated. This creates uncertainty: a company cannot predict when APRA will intervene. Seventh, there is no de minimis exemption. Even a guarantee cost of 0.5 per cent triggers the full requirements. The standard does not carve out small funds or products. Eighth, the standard does not define "investment performance guarantee". This may cause classification disputes. Some product features might be close to a guarantee (e.g., a bonus that is effectively guaranteed) and might be caught. Ninth, the standard references LPS 001 for definitions but does not reproduce them. A company must have access to that cross-referenced standard. Tenth, the standard has been in force since 2013, so there is no grandfathering for products issued before that date. Companies that wrote guaranteed business before 2013 and still have policy liabilities must comply now even if the calculation method is different from what was used at inception.

Compliance has four main limbs: valuation methodology, measurement systems, board oversight, and evidence of ongoing compliance. First, the company must adopt a valuation methodology that complies with paragraph 10. This requires determining the fair value of the financial instrument element with and without the investment performance guarantee. The company should document its methodology, including the valuation models used, key assumptions (such as discount rates, volatility assumptions, and correlation assumptions), and how it isolates the incremental value of the guarantee. The methodology must be consistent with relevant accounting standards (AASB 13, AASB 9). The company should also consider whether the methodology aligns with the broader policy liability valuation used for statutory fund solvency. The appointed actuary should provide an opinion on the reasonableness of the methodology. Second, the company must establish a process to calculate the investment performance guarantee factor at a frequency that meets the "at all times" standard. This will require system capability to recalculate the factor whenever there is a material market movement or at least daily. The company should set up a monitoring dashboard that shows the factor for each relevant statutory fund, including trends and headroom to the 5 per cent cap. The factor is the ratio of the total guarantee cost (the numerator) to the total current policy liabilities of the fund, gross of reinsurance (denominator). The company must ensure that the numerator and denominator use consistent data and valuation dates. Third, the board must take ultimate responsibility. The board should approve the valuation methodology, set a risk appetite for the guarantee factor (likely with a buffer below 5 per cent), and receive regular reports on the factor. The board should also consider scenario analysis to understand how the factor would move under adverse investment conditions. The company should have a documented policy for what actions it will take if the factor approaches 5 per cent. Possible actions include rebalancing the fund's assets, reducing the guarantee level on new business, increasing premiums or charges, hedging the guarantee risk, or injecting additional capital. The company should also have a breach management plan for if the factor exceeds 5 per cent. Fourth, the company must maintain evidence to demonstrate compliance. This is a specific requirement in the key objectives. The evidence should include: the valuation documentation, the model inputs and outputs, the monitoring reports, board meeting minutes, and any communications with APRA. The company should be able to produce this evidence on demand. The company should also consider external audit or internal audit review of the methodology and controls. If the company has an existing APRA approval or direction under a previous version of the standard, it should document how that approval continues under paragraph 12. The company should also stay alert for APRA updates or practice guides. While the standard itself is short, the compliance effort is significant. The 5 per cent cap may be easy to calculate for simple products but becomes complex for multi-asset funds with dynamic guarantee features. A company that is close to the cap should invest in hedging to reduce the guarantee cost. The company should also review its product range to assess whether any existing or new products could be classified as containing an investment performance guarantee. If in doubt, the company should seek legal and actuarial advice. Finally, the company should note that APRA has discretion under paragraph 11 to adjust or exclude requirements. If the company believes the standard is producing an anomalous result, it can approach APRA pre-emptively. However, the standard does not oblige APRA to respond.